Research Keyword: SARS-CoV-2

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

mycolabadmin

Scientists are searching for new treatments for COVID-19 by studying indole-containing compounds, which are found in many plants and can be made in laboratories. Some approved drugs with indole structures, like the antiviral drug Arbidol, have been repurposed to fight COVID-19. Researchers are also designing new indole compounds and using computer simulations to predict which ones might work best against the virus’s key proteins.

Read More »

Screening and identifying natural products with SARS-CoV-2 infection inhibitory activity from medicinal fungi

mycolabadmin

Researchers screened 167 extracts from 36 medicinal fungi to find natural compounds that could fight COVID-19. They discovered that certain fungi, particularly Inonotus obliquus and Pholiota adiposa, contain polysaccharides that effectively block the virus from infecting cells. These natural compounds showed promise as potential safe alternatives for developing new COVID-19 treatments and may have applications against other viral diseases.

Read More »

Comment on Subhadra et al. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2

mycolabadmin

This is a scientific critique of a recent study claiming that a plant extract called Bi121 has antiviral properties against SARS-CoV-2. The author raises important concerns about how the plant material was prepared and characterized, noting that the chemical fingerprint appears suspiciously identical to a previously published extract, and that the identification of the active ingredient relies on incomplete evidence. The critique calls for more rigorous scientific methods to verify the original study’s findings.

Read More »

Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris

mycolabadmin

Researchers tested an edible mushroom called Cordyceps militaris to see if it could fight SARS-CoV-2, the virus that causes COVID-19. Using computer modeling and laboratory experiments, they found that a compound in the mushroom called cordycepin strongly attached to the virus’s spike protein and reduced viral numbers by about 50% in cell cultures. The study supports traditional uses of this mushroom and suggests it could be helpful in managing COVID-19 as the disease becomes endemic.

Read More »
Scroll to Top